Navigation Links
Signalife Announces AFL Joins NIH Education Program
Date:6/17/2008

LOS ANGELES, June 17 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) and Athletes for Life Foundation announced that the Athletes for Life Foundation will conduct heart monitoring and screening at the Pontotoc Technology Center in Ada, Oklahoma. Willie Gault, Olympic gold medalist, Super Bowl champion, and a founder of the Athletes for Life Foundation, will be present on June 24-25th to participate in a children's health education program sponsored by the National Library of Medicine (NLM), a division of the National Institute of Health's (NIH).

The Athletes for Life Foundation has selected Signalife's award winning technology to perform heart monitoring and screening as part of the program's activities. The Signalife monitor is a 12 lead ambulatory ECG device capable of detecting subtle ECG changes that may be significant for early diagnosis of potential heart problems.

The Athletes for Life Foundation's co-founder, Willie Gault, commented: "I cannot begin to put into words how grateful I am to the NIH for inviting me to join their efforts in educating children. The foundation is bringing Signalife's heart monitoring and screening to the public, for free, as part of its continued effort to shift the healthcare balance from costly reactive heart disease treatments to early heart disease detection. A number of high profile sports and media personalities have recently passed away from heart disease. Perhaps use of this technology would have allowed life saving intervention. The foundation believes that providing annual heart screening for all people, before symptoms are apparent, can have an enormous impact in our efforts to save lives and lower the cost of healthcare throughout the world. We are thankful to all those who have supported our efforts to 'save lives, one heart at a time'."

About Athletes for Life Foundation

The Athletes for Life Foundation, http://www.athletes
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
2. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
3. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
4. Signalife Announces Webcast
5. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
6. Signalife Sees Accretive Purchase and Financial Commitments
7. Signalife Wins Second Frost & Sullivan Technology Award
8. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
9. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. U.S. Patent 7,299,083 Awarded to Signalife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... E-QURE Corp. (OTCQB: EQUR), a ... Signal Therapy device ("BST Device"), a new and novel ... chronic wounds, today announced that the Company has signed ... specializing in medical devices, for the marketing and distribution ... 70 years old, sales, marketing and distribution company in ...
(Date:8/3/2015)... Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... on the development of autologous cell therapies, announced today that ... the InvestMNT conference held in Minneapolis, Minnesota ... time. Hall,s presentation will highlight RepliCel,s 18-month milestones including CE ... Europe , clinical data from both RCT-01 (tendon) ...
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol Market 2015-2019 is ... on the global resorcinol industry. The report highlights the various growth prospects and ... and analysis of primary and secondary inputs from the existing players of the ...
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that it is ... to be held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive ... how agriculture impacts their daily lives. This unique exhibit also features a birthing center ...
Breaking Biology Technology:E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2
... , WALTHAM, Mass., Dec. 15 Repligen Corporation (Nasdaq: ... $731,000 in research funding to support the ongoing development of ... (MDA). This grant will support the completion of preclinical ... for human clinical trials. Support from the MDA not ...
... , , NEW YORK, ... research report is available in its catalogue: , ... Forecasts to 2015, Pipeline Analysis and Reimbursement ... Summary , The author has released its latest ...
... , WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... of Virginia (UVa) in Charlottesville, today announced that they ... development of new treatments primarily for coronary artery disease ... (PAD). , (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , The ...
Cached Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... Case Western Reserve University have found a way to create ... the developing heart in an animal model a key ... begun testing the technology to uncover how alcohol, drugs and ... in newborn humans. Passing blood cells drag on ...
... to rice cultivation built in the middle basin of the ... various migratory dabbling duck species to significantly increase in number ... that Vegas Altas del Guadiana is turned into a new ... populations are in decline and the loss of natural wetland ...
... - People tend to think of ozone as something ... from UV radiation. At the ground level, however, ozone ... Lisa Ainsworth, a University of Illinois associate professor of ... biologist, said that establishing the exposure threshold for damage ...
Cached Biology News:Finding triggers of birth defects in an embryo heart 2Ducks flock to Extremadura thanks to its ricefields 2Ducks flock to Extremadura thanks to its ricefields 3Ozone's impact on soybean yield: Reducing future losses 2Ozone's impact on soybean yield: Reducing future losses 3
... screening and binding optimization and built on ... synthesis platform. These microarrays are available as ... Service. Probe Content Our ... 1500 known aptamer sequences. Add up to ...
... LC Sciences provides a comprehensive service ... high density peptide microarrays synthesized on ... using recombinant proteins/antibodies or serum samples. ... your sequence designs, binding assays using ...
... a comprehensive epitope analysis service utilizing ... Paraflo microfluidic chips for immunological studies, ... comprehensive service includes assistance with your ... provided by you, single or dual ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. Thousands of customer specified ... LC Sciences can provide assistance with custom ... part of our comprehensive DNA/RNA Aptamer Microarray ...
Biology Products: